Han Gyung Kim

Dr. Han Gyung Kim

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Ginseng Research
Verified
Journal Article
Open access
JLJeong-Oog Lee
Jeong-Oog Lee
ECeunju choi
eunju choi
KSKon Kuk Shin
Kon Kuk Shin
YHYo Han Hong
Yo Han Hong
HKHan Gyung Kim
Han Gyung Kim
Jae Youl ChoJae Youl Cho
Jae Youl Cho
Compound K (CK) is an active metabolite of ginseng saponin, ginsenoside Rb1, that has been shown to have ameliorative properties in various diseases. However, its role in inflammation and the underlying mechanisms are poorly understood. In this report, the antiinflammatory role of CK was investigated in macrophage-like cells. The CK-mediated antiinflammatory mechanism was explored in RAW264.7 and HEK293 cells that were activated by lipopolysaccharide (LPS) or exhibited overexpression of known activation proteins. The mRNA levels of inflammatory genes and the activation levels of target proteins were identified by quantitative and semiquantitative reverse transcription polymerase chain reaction and Western blot analysis. CK significantly inhibited the mRNA expression of inducible nitric oxide synthase and tumor necrosis factor-α and morphological changes in LPS-activated RAW264.7 cells under noncytotoxic concentrations. CK downregulated the phosphorylation of AKT1, but not AKT2, in LPS-activated RAW264.7 cells. Similarly, CK reduced the AKT1 overexpression-induced expression of aldehyde oxidase 1, interleukin-1β, interferon-β, and tumor necrosis factor-α in a dose-dependent manner. Our results suggest that CK plays an antiinflammatory role during macrophage-mediated inflammatory actions by specifically targeting the AKT1-mediated signaling pathway.

1 July 2020 in Biochemical Pharmacology
Verified
Journal Article
Closed access
SHStephanie Triseptya Hunto
Stephanie Triseptya Hunto
HKHan Gyung Kim
Han Gyung Kim
KBKwang-Soo Baek
Kwang-Soo Baek
DJDeok Jeong
Deok Jeong
EKEunji Kim
Eunji Kim
Jae Youl ChoJae Youl Cho
Jae Youl Cho

1 July 2020 in Journal of Ginseng Research
Verified
Journal Article
Open access
JLJeong-Oog Lee
Jeong-Oog Lee
JKJi Hye Kim
Ji Hye Kim
SKSunggyu Kim
Sunggyu Kim
MKMi-Yeon Kim
Mi-Yeon Kim
YHYo Han Hong
Yo Han Hong
Jae Youl ChoJae Youl Cho
Jae Youl Cho
Korean Red Ginseng is known to exhibit immune-enhancing and anti-inflammatory properties. The immune-enhancing effects of the nonsaponin fraction (NSF) of Korean Red Ginseng have been studied in many reports. However, the gastroprotective effect of this fraction is not fully understood. In this study, we demonstrate the activities of NSF for gastrointestinal protection and its related critical factor. The in vitro and in vivo regulatory functions of NSF on cyclooxygenase-1 (COX-1) messenger RNA and protein levels were examined by reverse transcription polymerase chain reaction and immunoblotting analyses. Gastroprotective effects of NSF were investigated by histological score, gastric juice pH, and myeloperoxidase activity on indomethacin-induced, cold stress–induced, and acetylsalicylic acid–induced gastritis and dextran sulfate sodium–induced colitis in in vivo mouse models. NSF did not show cytotoxicity, and it increased COX-1 messenger RNA expression and protein levels in RAW264.7 cells. This upregulation was also observed in colitis and gastritis in vivo models. In addition, NSF treatment in mice ameliorated the symptoms of gastrointestinal inflammation, including histological score, colon length, gastric juice pH, gastric wall thickness, and myeloperoxidase activity. These results suggest that NSF has gastroprotective effects on gastritis and colitis in in vivo mouse models through COX-1 upregulation.

1 May 2019 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
CSChaoran Song
Chaoran Song
YHYo Han Hong
Yo Han Hong
JPJae Gwang Park
Jae Gwang Park
HKHan Gyung Kim
Han Gyung Kim
DJDeok Jeong
Deok Jeong
Jae Youl ChoJae Youl Cho
Jae Youl Cho

9 October 2020 in Molecules
Verified
Journal Article
Open access
PDF file
SPSang Hee Park
Sang Hee Park
JOJieun Oh
Jieun Oh
MJMinkyeong Jo
Minkyeong Jo
JKJin Kyeong Kim
Jin Kyeong Kim
DKDong Sun Kim
Dong Sun Kim
Jae Youl ChoJae Youl Cho
Jae Youl Cho
Muscle atrophy is an abnormal condition characterized by loss of skeletal muscle mass and function and is primarily caused by injury, malnutrition, various diseases, and aging. Leaf of lotus (Nelumbo nucifera Gaertn), which has been used for medicinal purposes, contains various active ingredients, including polyphenols, and is reported to exert an antioxidant effect. In this study, we investigated the effect of water extract of lotus leaf (LL) on muscle atrophy and the underlying molecular mechanisms of action. Amounts of 100, 200, or 300 mg/kg/day LL were administered to dexamethasone (DEX)-induced muscle atrophy mice for 4 weeks. Micro-computed tomography (CT) analysis revealed that the intake of LL significantly increased calf muscle volume, surface area, and density in DEX-induced muscle atrophy mice. Administration of LL recovered moving distance, grip strength, ATP production, and body weight, which were decreased by DEX. In addition, muscle damage caused by DEX was also improved by LL. LL reduced the protein catabolic pathway by suppressing gene expression of muscle atrophy F-Box (MAFbx; atrogin-1), muscle RING finger 1 (MuRF1), and forkhead box O (FoxO)3a, as well as phosphorylation of AMP-activated kinase (AMPK). The AKT-mammalian target of the rapamycin (mTOR) signal pathway, which is important for muscle protein synthesis, was increased in LL-administered groups. The HPLC analysis and pharmacological test revealed that quercetin 3-O-beta-glucuronide (Q3G) is a major active component in LL. Thus, Q3G decreased the gene expression of atrogin-1 and MuRF1 and phosphorylation of AMPK. This compound also increased phosphorylation levels of mTOR and its upstream enzyme AKT in DEX-treated C2C12 cells. We identified that LL improves muscle wasting through regulation of muscle protein metabolism in DEX-induced muscle atrophy mice. Q3G is predicted to be one of the major active phenolic components in LL. Therefore, we propose LL as a supplement or therapeutic agent to prevent or treat muscle wasting, such as sarcopenia.

14 May 2020 in Cells
Verified
Journal Article
Open access
PDF file
WYWOO SEOK YANG
WOO SEOK YANG
HKHan Gyung Kim
Han Gyung Kim
EKEunji Kim
Eunji Kim
SHSang Yun Han
Sang Yun Han
NANur Aziz
Nur Aziz
Jae Youl ChoJae Youl Cho
Jae Youl Cho
In this study, we investigated the functional role of isoprenylcysteine carboxyl methyltransferase (ICMT) and its methylatable substrate Ras in Toll-like receptor (TLR)-activated macrophages and in mouse inflammatory disease conditions. ICMT and RAS expressions were strongly increased in macrophages under the activation conditions of TLRs by lipopolysaccharide (LPS, a TLR4 ligand), pam3CSK (TLR2), or poly(I:C) (TLR3) and in the colons, stomachs, and livers of mice with colitis, gastritis, and hepatitis. The inhibition and activation of ICMT and Ras through genetic and pharmacological approaches significantly affected the activation of interleukin-1 receptor-associated kinase (IRAK)s, tumor necrosis factor receptor associated factor 6 (TRAF6), transforming growth factor-β-activated kinase 1 (TAK1), mitogen-activated protein kinase (MAPK), and MAPK kinases (MAPKKs); translocation of the AP-1 family; and the expressions of inflammation-related genes that depend on both MyD88 and TRIF. Interestingly, the Ras/ICMT-mediated inflammatory reaction critically depends on the TIR domains of myeloid differentiation primary response 88 (MyD88) and TIR-domain-containing adapter-inducing interferon-β (TRIF). Taken together, these results suggest that ICMT and its methylated Ras play important roles in the regulation of inflammatory responses through cooperation with the TIR domain of adaptor molecules.